Brown, Lisle/Cummings, Inc. Pfizer Inc Transaction History
Brown, Lisle/Cummings, Inc.
- $329 Billion
- Q3 2024
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 57,484 shares of PFE stock, worth $1.51 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
57,484
Previous 57,326
0.28%
Holding current value
$1.51 Million
Previous $1.6 Billion
3.72%
% of portfolio
0.51%
Previous 0.52%
Shares
12 transactions
Others Institutions Holding PFE
# of Institutions
3,267Shares Held
3.73BCall Options Held
74.2MPut Options Held
108M-
Vanguard Group Inc Valley Forge, PA511MShares$13.4 Billion0.28% of portfolio
-
Black Rock Inc. New York, NY424MShares$11.1 Billion0.27% of portfolio
-
State Street Corp Boston, MA287MShares$7.52 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA166MShares$4.36 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA130MShares$3.41 Billion0.73% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $147B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...